TH22472U - Pharmaceutical composition for topical use which has specific characteristics that The composition includes Esladpagpon extract and hemp extract. - Google Patents

Abstract

Pharmaceutical composition for topical use which consists of extracts From Saledpangpon and hemp extracts and the process of producing said composition, which said composition includes paraben, Vaseline, canchialilla, bee wax, mint flakes, borneol, camphor, menthol water solution, wintergreen extract, Eucalyptus extract, mint extract, clove extract, Esldpagphon extract in an amount of approximately 2 to 20 percent by weight, is obtained by extracting leaves, stems and/or seeds of Esldapangphon. and hemp extract in an amount of approximately 0.05 to 2 percent by weight, obtained by extracting the leaves, stems and/or seeds of hemp. and pharmaceutically acceptable additives There are outstanding properties from Saledpangphon. To relieve symptoms Inflammation from insect bites, herpes and shingles, and relief from body aches and pains from hemp extract, adding value to Thai herbs. and make Thai herbal products known and received International popularity

Claims (10)

1. Pharmaceutical composition for topical use, characterized by the inclusion of extracts of Clinacanthus nutans, hemp extract, and pharmaceutically acceptable additives. 2. The composition as per claim 1, which contains 2 to 20 percent by weight of the Clinacanthus nutans extract. 3. Components as per claim 1 or 2, containing hemp extract in an amount of 0.05 to 2 percent by weight. 4. Any one of the components under claims 1 through 3 in which the extract of Clinacanthus nutans is obtained from the extraction of the leaves, stems and/or seeds of Clinacanthus nutans. 5. One of the four claims under the patent states that the hemp extract is obtained from the extraction of hemp leaves, stems, and/or seeds. 6. Any one of the components under Reservations 1 through 5, where at least one additive is selected from paraffin, Vaseline, Candiallilla, beeswax, menthol crystals, camphor, borneol, menthol aqueous solution, eudaeuptus extract, cypress extract, peppermint extract, or clove extract. 7. Components as specified in any one of Claims 1 to 2, for use in the manufacture of pharmaceuticals. 8. Components under claim 7 where the pharmaceutical product is in the form of balm, ointment, cream, gel, solution, spray or patch. 9. The manufacturing process for the components under claim 1, which includes: a. Mixing 2-30% by weight of paraffin, 5-70% by weight of Vaseline, 1-30% by weight of candiella, and 2-30% by weight of beeswax, then heating and stirring the mixture to obtain component 1; b. Mixing 2-30% by weight of menthol crystals, 2-30% by weight of camphor, 2-30% by weight of borneol, and 2-30% by weight of aqueous menthol solution, then heating and stirring the mixture to obtain component 2; c. Mixing components 1 and 2 to obtain component 3; D. Add 2-30% by weight of eucalyptus extract, 2-20% by weight of peppermint extract, 2-20% by weight of clove extract, 2-20% by weight of Clinacanthus nutans extract, and 0.05-2% by weight of hemp extract to mixture 3 and stir thoroughly to obtain the pharmaceutical composition for topical use in the form of a balm. 10. Manufacturing procedure for the components under claim 1, which includes: a. Mixing 2-40% by weight of menthol crystals, 2-40% by weight of borneol, 2-40% by weight of camphor, and 2-30% by weight of aqueous menthol solution, then heating and stirring the mixture to obtain component 1; b. Adding 2-30% by weight of eucalyptus extract, 2-30% by weight of peppermint extract, 2-30% by weight of clove extract, 2-30% by weight of Clinacanthus nutans extract, and 0.05-2% by weight of hemp extract to component 1, then stirring the mixture to obtain the pharmaceutical components for topical use in the form of a liquid balm.